Go back to Resource Center
Effect of the orally administered PKC b Inhibitor, Ruboxistaurin, on sustained moderate visual loss in the PKC-DRS2 Study
2006
Journal Article
Authors:
Brucker, A.;
Aiello, L.P.;
Vignati, L.;
Sheetz, M.J.;
Zhi, X.;
Girach, A.;
Davis, M.D.;
Group, R.C.Milton for
Location: Sao Paulo, Brazil
Go back to Resource Center